Foot Perfusion by Dynamic Contrast Enhanced MRI in Patients With Peripheral Artery Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-08-01

Study Completion Date

2024-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

We investigate the peri-operative foot perfusion through dynamic contrast enhanced MRI in patients with peripheral artery disease

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease

NCT03622359

Peripheral Artery Disease Diabetes Mellitus Chronic Limb-Threatening Ischemia

RECRUITING NA

Functional MRI of the Lower Extremities

NCT03423316

Peripheral Arterial Disease

UNKNOWN NA

Magnetic Resonance Imaging to Identify Characteristics of Plaque Build-Up in People With Peripheral Arterial Disease

NCT00520312

Peripheral Vascular Diseases

COMPLETED

Clinical Use of Magnetic Resonance Perfusion Imaging to Qualitatively Assess Adequate Distal Perfusion After Endovascular Revascularization in Critical Limb Ischemia

NCT02646150

Lower Limb Ischemia Perfusion

COMPLETED

SPECT/CT Imaging of Skeletal Muscle Perfusion

NCT02791204

Peripheral Arterial Disease Diabetes Mellitus

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peripheral Arterial Disease Perfusion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PAD group

patients of peripheral artery disease who underwent endovascular treatment

DCE MRI

Intervention Type DIAGNOSTIC_TEST

the recruited patients should complete pre- and post-operative DCE MRI workshops

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

DCE MRI

the recruited patients should complete pre- and post-operative DCE MRI workshops

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 to 80 years old;
* PAD patients with Fontaine grade II-IV or Rutherford grade 2-6 and underwent a successful revascularization;
* Patients completed both pre- and post-operative MRI workups;
* Patients signed the informed consent form and be able to complete the clinical follow-up for 1 months.

Exclusion Criteria

* Patients has participated in other clinical studies;
* Patients with Heart failure (NYHA III/IV)/right to left shunt heart disease/ severe aortic and mitral insufficiency/acute coronary syndrome/malignant arrhythmia/severe pulmonary hypertension (pulmonary artery pressure at least 90 mmHg)/moderate to severe renal insufficiency (creatinine clearance rate\<60 ml/min)
* Any allergic constitution;
* Pregnancy and childbirth;
* Life expectancy\<12 months.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No